Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide for Acute Chest Syndrome in Sickle Cell Disease
NCT01089439Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2010
- Primary completion
- Nov 2013
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in acute chest syndrome (ACS), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2010; status: completed.
02
Drugs
nitric oxide
03
Conditions
acute chest syndrome (ACS)
Beyond the preview
Go deeper on NCT01089439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01089439.